| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
4,842.40
|
|
Change (%)
|
-97.00 (-1.96%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
4,792.50
-
4,959.90
|
|
52-Week Range (RS)
|
4,727.90
-
6,700.00
|
|
Beta (1 Year)
|
0.27
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Board of Procter & Gamble Health recommends Interim Dividend |
| Board of Procter & Gamble Health recommends One-time Special Dividend |
| Procter & Gamble Health fixes record date for interim dividend |
| Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter |
| Procter & Gamble Health to declare Quarterly Results |
| Procter & Gamble Health standalone net profit rises 7.54% in the September 2025 quarter |
| Procter & Gamble Health Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| Procter & Gamble Health Ltd - Revision of Board Meeting |
| Procter & Gamble Health Ltd - Allotment Of DIN To Mr. Shashank Srowthy Executive Director |
|
|
|
| Incoporation Year : 1967 |
| Chairman : S Madhavan |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Procter & Gamble Health Ltd
Godrej One 8th Floor,
Projshanagar Vikhroli (East),
Mumbai,
Maharashtra-400079 |
Phone:91-22-62109000
Fax:91-22-62109999 |
| E-Mail : investorgrievance.im@pg.com |
| URL : http://www.pghealthindia.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
20-Mar-2026 |
4870.50 |
-0.58 |
| 1Month |
27-Feb-2026 |
4911.10 |
-1.40 |
| 3Month |
29-Dec-2025 |
5684.25 |
-14.81 |
| 6Month |
29-Sep-2025 |
6302.15 |
-23.16 |
| 1Year |
27-Mar-2025 |
4997.40 |
-3.10 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.50 |
339.44 |
| ICICI Pru Smallcap Fund |
2.14 |
178.87 |
| UTI-MNC Fund |
4.13 |
112.50 |
| DSP Healthcare Fund |
2.57 |
78.06 |
| Aditya Birla SL MNC Fund |
1.14 |
39.06 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
26,155.40 |
-0.92 |
35,921.55 |
25,350.00 |
55,580.23 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,259.20 |
-2.69 |
3,515.95 |
2,220.00 |
38,272.21 |
| Pfizer Ltd |
4,688.15 |
-0.32 |
5,987.65 |
3,742.90 |
21,447.22 |
| Astrazeneca Pharma India Ltd |
7,946.10 |
-5.58 |
10,653.05 |
6,501.60 |
19,865.25 |
| Sanofi Consumer Healthcare India Ltd |
4,088.55 |
-3.00 |
5,954.00 |
3,950.50 |
9,416.18 |
|
|
|
|